Search

everythinglearnresearchcommunity

for

Search:↓

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Goat placenta extract in a special delivery system improved hair growth and thickness in chemotherapy patients.

The nano-carrier makes etoposide safer and more effective against lung cancer.

Anthracycline and taxane chemotherapy cause significant side effects like fatigue, vomiting, nausea, nerve damage, joint pain, and hair loss in breast cancer patients.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

MVP treatment is effective and safe for recurrent breast cancer.

Etoposide is effective in treating several cancers, especially small cell lung cancer, with acceptable side effects.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

TPA is about 50 times more effective at promoting tumors than MZ.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Cancer treatments often cause skin, nail, and hair problems.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Photobiomodulation therapy may speed up hair regrowth after chemotherapy in the short term.

The committee decided not to approve the drug due to low effectiveness and high risks.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.